Table 3 Implementation details for each of the cancer centres
| Â | Implementation efforts begin | Started treating with IMRT | First disease site treated with IMRT | Subsequent disease sites treated | Percentage of patients treated with IMRT* |
|---|---|---|---|---|---|
Centre A | Late 1990's | 2001 | Prostate | All indicated disease sites | 56% |
Centre B | 2004 | 2008 | Prostate | None | 8% |
Centre C | 2004 | 2009 | Head and Neck | None | 0% |
Centre D | 2001 | 2004 | Head and Neck | Prostate | 16% |